Vicus Capital’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Vicus Capital’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.14M	Buy	+41,651	New	+$5.18M	0.33%	55

Other funds holding PJP

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return

Joseph Group Capital Management Columbus, Ohio $562M AUM 15.17% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

Institute for Wealth Management Denver, Colorado $1.13B AUM 31.46% 1-Year Est. Return

Outlook Wealth Advisors Shenandoah, Texas $470M AUM 20.06% 1-Year Est. Return

Dumont & Blake Investment Advisors Princeton, New Jersey $398M AUM 22.72% 1-Year Est. Return

Vicus Capital's PJP Position: Q3 2026 in Review

Vicus Capital opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q3 2026: 41,651 shares worth $5.14M. The stake represents 0.33% of the portfolio and ranks #55 among its holdings.

61 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

Vicus Capital held 41,651 shares of Invesco Pharmaceuticals ETF worth $5.14M as of Q3 2026.
Invesco Pharmaceuticals ETF was a new Vicus Capital position in Q3 2026.
Invesco Pharmaceuticals ETF made up 0.33% of Vicus Capital's portfolio in Q3 2026, its #55 holding.
61 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Vicus Capital's 13F filing for Q3 2026, filed 5 Nov 2026.